- Home
- BFRI vs HSCS Comparison
BFRI vs HSCS Comparison
Compare BFRI & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | HSCS |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 15.8M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BFRI | HSCS |
|---|---|---|
| Price | $0.89 | $3.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 484.2K | 140.0K |
| Earning Date | 11-11-2026 | 09-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | 50.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,705,000.00 | $4,319.00 |
| Revenue This Year | $10.65 | $295.93 |
| Revenue Next Year | $15.88 | $18,321.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $0.57 | $1.63 |
| 52 Week High | $1.66 | $5.25 |
Technical Indicators
Market Signals| Indicator | BFRI | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 31.47 | 41.08 |
| Support Level | $0.85 | $1.84 |
| Resistance Level | $0.97 | $3.67 |
| Average True Range (ATR) | 0.08 | 0.40 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 7.11 | 5.05 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.